Cite
Very Early Onset Inflammatory Bowel Disease Associated with Aberrant Trafficking of IL-10R1 and Cure by T Cell Replete Haploidentical Bone Marrow Transplantation.
MLA
Murugan, Dhaarini, et al. “Very Early Onset Inflammatory Bowel Disease Associated with Aberrant Trafficking of IL-10R1 and Cure by T Cell Replete Haploidentical Bone Marrow Transplantation.” Journal of Clinical Immunology, vol. 34, no. 3, Apr. 2014, pp. 331–39. EBSCOhost, https://doi.org/10.1007/s10875-014-9992-8.
APA
Murugan, D., Albert, M., Langemeier, J., Bohne, J., Puchalka, J., Järvinen, P., Hauck, F., Klenk, A., Prell, C., Schatz, S., Diestelhorst, J., Sciskala, B., Kohistani, N., Belohradsky, B., Müller, S., Kirchner, T., Walter, M., Bufler, P., Muise, A., & Snapper, S. (2014). Very Early Onset Inflammatory Bowel Disease Associated with Aberrant Trafficking of IL-10R1 and Cure by T Cell Replete Haploidentical Bone Marrow Transplantation. Journal of Clinical Immunology, 34(3), 331–339. https://doi.org/10.1007/s10875-014-9992-8
Chicago
Murugan, Dhaarini, Michael Albert, Jörg Langemeier, Jens Bohne, Jacek Puchalka, Päivi Järvinen, Fabian Hauck, et al. 2014. “Very Early Onset Inflammatory Bowel Disease Associated with Aberrant Trafficking of IL-10R1 and Cure by T Cell Replete Haploidentical Bone Marrow Transplantation.” Journal of Clinical Immunology 34 (3): 331–39. doi:10.1007/s10875-014-9992-8.